Singapore markets closed

Renault SA (0NQF.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
25.58-0.39 (-1.49%)
At close: 06:45PM BST
Full screen
Previous close25.96
Open25.88
BidN/A x N/A
AskN/A x N/A
Day's range25.82 - 26.00
52-week range25.82 - 43.94
Volume101,534
Avg. volume573,659
Market capN/A
Beta (5Y monthly)1.71
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Reuters SG

    UPDATE 2-Nissan will invest in Renault's Ampere in pursuit of global EV roadmap, CEO says

    Japan's Nissan Motor will invest in Renault's electric vehicle (EV) unit Ampere even after its listing plans fell through, while also evaluating its partnership with Honda Motor to further build its global EV expansion. "We want to be a global (EV) player in the world," Nissan CEO Makoto Uchida told reporters during a press briefing in the southern Indian city of Chennai on Wednesday, adding that the company wants to deepen its partnership with Renault, and through that, it's presence in Europe.

  • Reuters SG

    Nissan will invest in Renault EV unit even though IPO scrapped, CEO says

    Japan's Nissan Motor will invest in the electric vehicle unit of alliance partner Renault even though the French carmaker has decided not to list the unit, Nissan's CEO said on Wednesday. "We want to further our growth in Europe, we want to further have the leverage from the alliance," Nissan CEO Makoto Uchida told reporters during a press briefing in the southern Indian city of Chennai. The first visit to India by the chiefs of Renault and Nissan reflects the importance of the South Asian nation as a growth market, especially as carmakers face rising competition from Chinese rivals.

  • Reuters SG

    Deals of the day-Mergers and acquisitions

    ** Novo Nordisk notched a win in its race to boost output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent, a key manufacturing subcontractor of the product, for $16.5 billion. ** Brazilian fashion companies Arezzo & Co and Grupo Soma said they had agreed to a merger to form an entity with yearly revenues of 12 billion reais ($2.42 billion), which will be 54% controlled by Arezzo. ** Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said.